ADDERALL vs STRATTERA
Independent side-by-side comparison.
Both are FDA-approved for ADHD, but they are not the same kind of drug: Adderall is a stimulant and a Schedule II controlled substance, while Strattera is a non-stimulant that is not controlled. Which fits you is a prescriber's call.
The key difference
One difference that matters is what each drug is. Adderall is a stimulant (amphetamine); the DEA places it in Schedule II, and its boxed warning is for abuse, misuse, and addiction — the label warns this can lead to overdose and death, with higher risk at larger doses or if snorted or injected. A prescriber assesses that risk before and during treatment.
Strattera (atomoxetine) is a selective norepinephrine reuptake inhibitor — a non-stimulant that is not a controlled substance. Its boxed warning is a different one: an increased risk of suicidal ideation in children and adolescents, so a young patient starting it should be watched closely for mood or behavior changes, especially in the first months.
Both labels also carry cardiovascular warnings — sudden death has been reported with each in patients with structural cardiac abnormalities or serious heart disease — and both are contraindicated with MAO inhibitors (Adderall within 14 days, Strattera within 2 weeks).
What favours Adderall (amphetamine/dextroamphetamine)
Adderall works as a stimulant. It is a reason to lean this way when a prescriber judges a stimulant appropriate for the patient's ADHD. Because it is a Schedule II controlled substance, its abuse/misuse/addiction boxed warning shapes the decision: the prescriber weighs each person's risk before starting and keeps watching for signs of misuse. It is contraindicated with MAO inhibitors and avoided in known serious cardiac disease.
What favours Strattera (atomoxetine)
Strattera is the labelled option when a non-stimulant, non-controlled medicine is what's wanted — for example where a prescriber wants to avoid a controlled stimulant, or a stimulant is otherwise unsuitable. It carries its own boxed warning for increased suicidal ideation in children and adolescents, so close monitoring early on matters. It too is contraindicated with MAO inhibitors and in narrow-angle glaucoma, pheochromocytoma, or severe cardiovascular disorders.
Bottom line
Unlike many "X vs Y" pairs the internet blurs together, these two genuinely differ: a controlled stimulant versus a non-controlled non-stimulant, each with its own boxed warning. That is a labelled difference your prescriber weighs against your history, not something to settle by price or reviews. We rate drugs on their FDA recall record and sell neither the medicines nor coupons, so we can say it plainly — this is a medical decision. Use this as a starting point, not a substitute for the FDA label or your clinician.
This is not a summary of either drug’s FDA label, and it is not complete. Both labels carry warnings, contraindications and interactions that are not on this page. Read the label for the drug you are actually taking — we link both above — and take the decision to your prescriber.
Possible drug interaction. ADDERALL and STRATTERA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.
Rating
Pharmacy pays
Type
Active ingredient
Manufacturer
Dosage forms
Drug class
Boxed warning
Half-life
Treats
Frequently asked questions
- What is the difference between Adderall and Strattera?
- Adderall contains Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate, while Strattera contains Atomoxetine Hydrochloride — they have different active ingredients.
Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.